Real‐world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases

por Volkers, Adriaan, Straatmijer, Tessa, Duijvestein, Marjolijn, Sales, Amber, Levran, Amit, van Schaik, Fiona, Maljaars, Jeroen, Gecse, Krisztina, Ponsioen, Cyriel, Grootjans, Joep, Hanzel, Jurij, Tack, Greetje, Jansen, Jeroen, Hoentjen, Frank, de Boer, Nanne, van der Marel, Sander, Dijkstra, Gerard, Oldenburg, Bas, Löwenberg, Mark, van der Meulen, Andrea, D′Haens, Geert
Publicado 2022

Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time

por de Groot, Pieter, Scheithauer, Torsten, Bakker, Guido J, Prodan, Andrei, Levin, Evgeni, Khan, Muhammad Tanweer, Herrema, Hilde, Ackermans, Mariette, Serlie, Mireille J M, de Brauw, Maurits, Levels, Johannes H M, Sales, Amber, Gerdes, Victor E, Ståhlman, Marcus, Schimmel, Alinda W M, Dallinga-Thie, Geesje, Bergman, Jacques JGHM, Holleman, Frits, Hoekstra, Joost B L, Groen, Albert, Bäckhed, Fredrik, Nieuwdorp, Max
Publicado 2020